According to Biotest 's latest financial reports the company's current EPS (TTM) is -ยฃ0.22. In 2022 the company made an earnings per share (EPS) of -ยฃ0.67 an increase over its 2021 EPS that were of -ยฃ1.46.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -ยฃ0.27 | -60.18% |
2022 | -ยฃ0.67 | -54.27% |
2021 | -ยฃ1.46 | 99.36% |
2020 | -ยฃ0.73 | 471.15% |
2019 | -ยฃ0.13 | -103.03% |
2018 | ยฃ4.22 | -9663.05% |
2017 | -ยฃ0.04412 | -95.43% |
2016 | -ยฃ0.97 | -47.94% |
2015 | -ยฃ1.86 | -468.28% |
2014 | ยฃ0.50 | -42.66% |
2013 | ยฃ0.88 | -8.51% |
2012 | ยฃ0.96 | -31.45% |
2011 | ยฃ1.40 | 30.12% |
2010 | ยฃ1.08 | 36.09% |
2009 | ยฃ0.79 |